LncRNA ASMTL-AS1/microRNA-1270 differentiate prognostic groups in gastric cancer and influence cell proliferation, migration and invasion

ABSTRACT The objective of this study was to determine the expression levels of ASMTL-AS1 and miR-1270 in gastric cancer, and to explore whether ASMTL-AS1 and miR-1270 is associated with cancer prognosis and progression or not. ASMTL-AS1 and miR-1270 expression were quantified in gastric cancer tissues and adjacent normal tissues (n = 167) and cell lines. The potential of ASMTL-AS1 and miR-1270 as prognostic biomarkers was evaluated by the receiver operating characteristic (ROC) curve, Kaplan-Meier, and multivariate Cox regression analyses. The binding between ASMTL-AS1 and miR-1270 was verified by the Luciferase reporter assay and RNA pull-down assay. Functional roles of ASMTL-AS1/miR-1270 on cells were investigated in HGC-27 and NCI-N87 cells by MTS viability, Transwell migration, and Matrigel invasion assay. ASMTL-AS1 was significantly downregulated while miR-1270 was upregulated in gastric cancer tissues as compared with normal tissue and cell lines. According to the studies, ASMTL-AS1 and miR-1270 were related to unfavorable clinical parameters, such as the advanced TNM stage. Downregulated ASMTL-AS1 and upregulated miR-1270 were associated with reduced 5‐year overall survival. Functional studies suggested that ASMTL-AS1 inhibits proliferation, migration, and invasion of HGC-27 and NCI-N87 cells by regulation of miR-1270. In summary, ASMTL-AS1 and miR-1270 are associated with poor prognosis of patients with gastric cancer. ASMTL-AS1 inhibited gastric cancer progression by regulating miR-1270. Therefore, ASMTL-AS1/miR-1270 may be a potential prognostic biomarker and novel strategy for gastric cancer targeted therapy.

[1]  Yanjie Mou,et al.  The long non-coding RNA ASMTL-AS1 promotes hepatocellular carcinoma progression by sponging miR-1343-3p that suppresses LAMC1 (laminin subunit gamma 1) , 2021, Bioengineered.

[2]  Pengbo Wang,et al.  ASMTL‐AS1 impedes the malignant progression of lung adenocarcinoma by regulating SAT1 to promote ferroptosis , 2021, Pathology international.

[3]  F. Sun,et al.  Long non-coding RNA ASMTL-AS1 deteriorates the oncogenicity of osteosarcoma by decoying microRNA-342-3p and consequently raising ADAM9 expression. , 2021, Biochemical and biophysical research communications.

[4]  Xiaohua Li,et al.  A novel tumor suppressor ASMTL-AS1 regulates the miR-1228-3p/SOX17/β-catenin axis in triple‐negative breast cancer , 2021, Diagnostic Pathology.

[5]  J. Liu,et al.  A Novel Tumor Suppressor ASMTL-AS1 Regulates the Mir-1228-3p/SOX17/Β-Catenin Axis in Triple-Negative Breast Cancer , 2021 .

[6]  Derong Yin,et al.  Silencing of long non-coding RNA HCP5 inhibits proliferation, invasion, migration, and promotes apoptosis via regulation of miR-299-3p/SMAD5 axis in gastric cancer cells , 2020, Bioengineered.

[7]  S. Markowitz,et al.  Epigenetic alterations in the gastrointestinal tract: Current and emerging use for biomarkers of cancer. , 2020, Gastroenterology.

[8]  Kunbin Ke,et al.  Extracellular Matrix–Related Six-lncRNA Signature as a Novel Prognostic Biomarker for Bladder Cancer , 2020, OncoTargets and therapy.

[9]  G. Goodall,et al.  RNA in cancer , 2020, Nature reviews. Cancer.

[10]  S. Ikeda,et al.  Gastric cancer mortality rates by occupation and industry among male and female workers aged 25–64 years in Japan , 2020, Industrial health.

[11]  A. Azmi,et al.  Gastric cancer: a comprehensive review of current and future treatment strategies , 2020, Cancer and Metastasis Reviews.

[12]  Ning Zhang,et al.  Exosome‐transferred long non‐coding RNA ASMTL‐AS1 contributes to malignant phenotypes in residual hepatocellular carcinoma after insufficient radiofrequency ablation , 2020, Cell proliferation.

[13]  Q. Shu,et al.  Non-coding RNAs in gastric cancer. , 2020, Cancer letters.

[14]  P. Dickman,et al.  Cancer survival statistics for patients and healthcare professionals – a tutorial of real‐world data analysis , 2020, Journal of internal medicine.

[15]  Chaoyuan Luo,et al.  Long non-coding RNA ASMTL-AS1 inhibits tumor growth and glycolysis by regulating the miR-93-3p/miR-660/FOXO1 axis in papillary thyroid carcinoma. , 2020, Life sciences.

[16]  Min Zhang,et al.  Long non-coding RNA LOC285194 regulates vascular smooth muscle cell apoptosis in atherosclerosis , 2019, Bioengineered.

[17]  Ketong Liu,et al.  LINC00528 regulates myocardial infarction by targeting the miR-143-3p/COX-2 axis , 2019, Bioengineered.

[18]  X. Chen,et al.  Identification of circulating miRNAs as novel prognostic biomarkers for bladder cancer. , 2019, Mathematical biosciences and engineering : MBE.

[19]  F. Slack,et al.  The Role of Non-coding RNAs in Oncology , 2019, Cell.

[20]  J. Edwards,et al.  Advancing Pan-cancer Gene Expression Survial Analysis by Inclusion of Non-coding RNA , 2019, RNA biology.

[21]  Hongcheng Lu,et al.  Circular RNA Cdr1as sensitizes bladder cancer to cisplatin by upregulating APAF1 expression through miR‐1270 inhibition , 2019, Molecular oncology.

[22]  Chunsheng Wang,et al.  Integrative analysis reveals driver long non-coding RNAs in osteosarcoma , 2019, Medicine.

[23]  Chen Li,et al.  MicroRNA‐1270 is associated with poor prognosis and its inhibition yielded anticancer mechanisms in human osteosarcoma , 2018, IUBMB life.

[24]  Yvonne Tay,et al.  Noncoding RNA:RNA Regulatory Networks in Cancer , 2018, International journal of molecular sciences.

[25]  Tieliu Shi,et al.  A functional SNP in the 3′‐UTR of TAP2 gene interacts with microRNA hsa‐miR‐1270 to suppress the gene expression , 2018, Environmental and molecular mutagenesis.

[26]  F. Slack,et al.  Non-coding RNA networks in cancer , 2017, Nature Reviews Cancer.

[27]  M. Copetti,et al.  MicroRNA co-expression networks exhibit increased complexity in pancreatic ductal compared to Vater's papilla adenocarcinoma , 2017, Oncotarget.

[28]  D. Graham,et al.  Changing Trends in Stomach Cancer Throughout the World , 2017, Current Gastroenterology Reports.

[29]  Wei Liu,et al.  Frequent Gene Amplification Predicts Poor Prognosis in Gastric Cancer , 2012, International journal of molecular sciences.

[30]  Hanlin Gao,et al.  MicroRNA profiling of clear cell renal cell carcinoma by whole‐genome small RNA deep sequencing of paired frozen and formalin‐fixed, paraffin‐embedded tissue specimens , 2010, The Journal of pathology.

[31]  D. Heo,et al.  The expression of MHC class I, TAP1/2, and LMP2/7 gene in human gastric cancer cell lines. , 2000, International Journal of Oncology.

[32]  U. Weidle,et al.  microRNAs Promoting Growth of Gastric Cancer Xenografts and Correlation to Clinical Prognosis , 2021, Cancer Genomics & Proteomics.

[33]  Lan Ge,et al.  MicroRNA-1270 modulates papillary thyroid cancer cell development by regulating SCAI. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[34]  Marco Pellegrini,et al.  Interplay Between Long Noncoding RNAs and MicroRNAs in Cancer. , 2018, Methods in molecular biology.

[35]  Kai Huang,et al.  Non-coding RNAs as regulators in epigenetics (Review). , 2017, Oncology reports.

[36]  H. Espejo,et al.  [Gastric cancer]. , 1996, Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru.